Production (Stage)
Appili Therapeutics Inc.
APLIF
$0.0137
$0.001916.10%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 854.50K | 129.40K | 492.40K | 220.10K | 69.80K |
| Total Receivables | 1.16M | 1.22M | 555.70K | 1.31M | 866.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 79.70K | 87.40K | 83.40K | 85.30K | 142.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.10M | 1.44M | 1.13M | 1.61M | 1.08M |
|
|
|||||
| Total Current Assets | 2.10M | 1.44M | 1.13M | 1.61M | 1.08M |
| Net Property, Plant & Equipment | 13.20K | 15.50K | 19.00K | 19.60K | 22.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.11M | 1.46M | 1.15M | 1.63M | 1.10M |
|
|
|||||
| Total Accounts Payable | 2.80M | 3.05M | 3.09M | 3.30M | 3.03M |
| Total Accrued Expenses | 61.70K | 27.10K | 19.20K | 9.50K | 55.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.04M | 7.28M | 7.11M | 6.72M | 5.40M |
| Total Finance Division Other Current Liabilities | 20.50K | 1.30K | 31.50K | 31.50K | 34.80K |
| Total Other Current Liabilities | 20.50K | 1.30K | 31.50K | 31.50K | 34.80K |
| Total Current Liabilities | 10.92M | 10.36M | 10.26M | 10.06M | 8.52M |
|
|
|||||
| Total Current Liabilities | 10.92M | 10.36M | 10.26M | 10.06M | 8.52M |
| Long-Term Debt | 512.10K | 563.90K | 602.60K | 621.30K | 646.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.43M | 10.93M | 10.86M | 10.68M | 9.17M |
|
|
|||||
| Common Stock & APIC | 39.75M | 39.71M | 41.06M | 40.52M | 40.76M |
| Retained Earnings | -49.90M | -50.00M | -52.87M | -- | -51.02M |
| Treasury Stock & Other | 820.30K | 819.40K | 2.10M | -49.57M | 2.20M |
| Total Common Equity | -9.32M | -9.47M | -9.71M | -9.05M | -8.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.32M | -9.47M | -9.71M | -9.05M | -8.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.32M | -9.47M | -9.71M | -9.05M | -8.07M |
|
|
|||||